Epilepsy surgery in the first months of life: a large type IIb focal cortical dysplasia causing neonatal drug-resistant epilepsy.


Journal

Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853

Informations de publication

Date de publication:
01 Feb 2019
Historique:
pubmed: 21 2 2019
medline: 18 6 2019
entrez: 21 2 2019
Statut: ppublish

Résumé

Focal cortical dysplasia is a common cause of medically refractory epilepsy in infancy and childhood. We report a neonate with seizures occurring within the first day of life. Continuous video-EEG monitoring led to detection of left motor seizures and a right frontal EEG seizure pattern. Brain MRI revealed a lesion within the right frontal lobe without contrast enhancement. The patient was referred for epilepsy surgery due to drug resistance to vitamin B6 and four antiepileptic drugs. Lesionectomy was performed at the age of two and a half months, and histopathological evaluation confirmed the diagnosis of focal cortical dysplasia type IIb (FCD IIb). The patient is free of unprovoked seizures without medication (Engel Class I) and is normally developed at 36 months after surgery. The case study demonstrates that FCD IIb may cause seizures within the first day of life and that epilepsy surgery can be successfully performed in medically intractable patients with a clearly identifiable seizure onset zone within the first three months of life. Although radical surgery such as hemispherectomy and multi-lobar resections are over-represented in early infancy, this case also illustrates a favourable outcome with a more limited resection in this age group.

Identifiants

pubmed: 30782583
pii: epd.2019.1037
doi: 10.1684/epd.2019.1037
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-127

Auteurs

Ingo Borggraefe (I)

Divison of Pediatric Neurology, Developmental Neurology and Social Pediatrics, Department of Pediatrics, University Hospital LMU Munich, Epilepsy Center for children, adolescents and adults, University Hospital LMU Munich.

Moritz Tacke (M)

Divison of Pediatric Neurology, Developmental Neurology and Social Pediatrics, Department of Pediatrics, University Hospital LMU Munich.

Lucia Gerstl (L)

Divison of Pediatric Neurology, Developmental Neurology and Social Pediatrics, Department of Pediatrics, University Hospital LMU Munich.

Steffen Leiz (S)

Department of Pediatrics and Adolescent Medicine, Hospital Dritter Orden, Munich.

Roland Coras (R)

Department of Neuropathology, Neuropathological Reference Center for Epilepsy Surgery, University Hospital Erlangen, Erlangen.

Ingmar Blümcke (I)

Department of Neuropathology, Neuropathological Reference Center for Epilepsy Surgery, University Hospital Erlangen, Erlangen.

Armin Giese (A)

Department of Neuropathology, University Hospital LMU, Munich.

Birgit Ertl-Wagner (B)

Department of Radiology, University Hospital LMU, Munich.

Christian T Thiel (CT)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen.

Soheyl Noachtar (S)

Epilepsy Center for children, adolescents and adults, University Hospital LMU Munich, Department of Neurology, University Hospital LMU, Munich.

Aurelia Peraud (A)

Department of Neurosurgery, Section for Pediatric Neurosurgery, University of Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH